Maximising use of population data on cardiometabolic diseases
- PMID: 35026159
- PMCID: PMC10072128
- DOI: 10.1016/S2213-8587(21)00328-4
Maximising use of population data on cardiometabolic diseases
Conflict of interest statement
No support was received for writing this manuscript. Authors declare the following support or relationships within 36 months of submitting the work. DF reports a Pilot and Feasibility Grant funded by the Michigan Center for Diabetes Translational Research (US National Institutes of Health grant P30-DK092926) and a grant from the Swinmurn Foundation to implement a sustainable diabetes clinic in Guatemala. DF also reports volunteer affiliations with Wuqu' Kawoq and GlucoSalud. DF has received research fellowship funding from the National Clinician Scholars Program at the University of Michigan Institute for Healthcare Policy and Innovation. TB reports grants from the Alexander von Humboldt Foundation, Wellcome Trust, and US National Institutes of Health. RA reports contracts with Novo Nordisk, the Union for International Cancer Control, Novo Nordisk, Hoffman-La Roche, and Sloan Memorial Kettering Hospital. RA also reports payments or honorario from Merck and Hoffmann-La Roche. JD reports grants from UK MRC and National Institute for Health Research, and US National Institute of Health. All other authors declare no competing interests.
Figures
References
-
- Davies J, Yudkin JS, Atun R. Liberating data: the crucial weapon in the fight against NCDs. Lancet Diabetes Endocrinol 2016; 4: 197–8. - PubMed
-
- Geldsetzer P, Manne-Goehler J, Marcus ME, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1∙1 million adults. Lancet 2019; 394: 652–62. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
